These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 17979648)

  • 41. Transdermal delivery of an analgesic agent using elastic liposomes: preparation, characterization and performance evaluation.
    Jain S; Jain N; Bhadra D; Tiwary AK; Jain NK
    Curr Drug Deliv; 2005 Jul; 2(3):223-33. PubMed ID: 16305424
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Formulation and evaluation of once-a-day transdermal gels of diclofenac diethylamine.
    Baboota S; Shakeel F; Kohli K
    Methods Find Exp Clin Pharmacol; 2006 Mar; 28(2):109-14. PubMed ID: 16636721
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nanostructured lipid carriers to enhance transdermal delivery and efficacy of diclofenac.
    Nguyen CN; Nguyen TTT; Nguyen HT; Tran TH
    Drug Deliv Transl Res; 2017 Oct; 7(5):664-673. PubMed ID: 28776220
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development and evaluation of nanosized niosomal dispersion for oral delivery of Ganciclovir.
    Akhter S; Kushwaha S; Warsi MH; Anwar M; Ahmad MZ; Ahmad I; Talegaonkar S; Khan ZI; Khar RK; Ahmad FJ
    Drug Dev Ind Pharm; 2012 Jan; 38(1):84-92. PubMed ID: 21726136
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A novel transdermal patch incorporating meloxicam: in vitro and in vivo characterization.
    Ah YC; Choi JK; Choi YK; Ki HM; Bae JH
    Int J Pharm; 2010 Jan; 385(1-2):12-9. PubMed ID: 19833177
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Niosomal gel of lornoxicam for topical delivery: in vitro assessment and pharmacodynamic activity.
    Kumbhar D; Wavikar P; Vavia P
    AAPS PharmSciTech; 2013 Sep; 14(3):1072-82. PubMed ID: 23818079
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nanostructured lipid carriers (NLC) based topical gel of flurbiprofen: design, characterization and in vivo evaluation.
    Han F; Yin R; Che X; Yuan J; Cui Y; Yin H; Li S
    Int J Pharm; 2012 Dec; 439(1-2):349-57. PubMed ID: 22989987
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Studies on the development of colon-targeted delivery systems for celecoxib in the prevention of colorectal cancer.
    Krishnaiah YS; Satyanarayana V; Kumar BD; Karthikeyan RS
    J Drug Target; 2002 May; 10(3):247-54. PubMed ID: 12075826
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Magnesium ascorbyl phosphate vesicular carriers for topical delivery; preparation, in-vitro and ex-vivo evaluation, factorial optimization and clinical assessment in melasma patients.
    Kandil SM; Soliman II; Diab HM; Bedair NI; Mahrous MH; Abdou EM
    Drug Deliv; 2022 Dec; 29(1):534-547. PubMed ID: 35156490
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preparation, optimization, and evaluation of Zaltoprofen-loaded microemulsion and microemulsion-based gel for transdermal delivery.
    Mishra R; Prabhavalkar KS; Bhatt LK
    J Liposome Res; 2016 Dec; 26(4):297-306. PubMed ID: 26785055
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of the selective COX-2 inhibitors, celecoxib and rofecoxib in rat acute models of inflammation.
    Pinheiro RM; Calixto JB
    Inflamm Res; 2002 Dec; 51(12):603-10. PubMed ID: 12558194
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Enhancement of 8-methoxypsoralen topical delivery via nanosized niosomal vesicles: Formulation development, in vitro and in vivo evaluation of skin deposition.
    Kassem AA; Abd El-Alim SH; Asfour MH
    Int J Pharm; 2017 Jan; 517(1-2):256-268. PubMed ID: 27956194
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sustained transdermal delivery of human growth hormone from niosomal gel:
    Wang L; Wei L; Long W; Zhang Q; Zou Y
    J Biomater Sci Polym Ed; 2022 Jun; 33(9):1198-1212. PubMed ID: 35192434
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The analgesic actions of centrally administered celecoxib are mediated by endogenous opioids.
    Rezende RM; Dos Reis WG; Duarte ID; Lima PP; Bakhle YS; de Francischi JN
    Pain; 2009 Mar; 142(1-2):94-100. PubMed ID: 19186002
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nanoemulsion based gel for transdermal delivery of meloxicam: physico-chemical, mechanistic investigation.
    Khurana S; Jain NK; Bedi PM
    Life Sci; 2013 Mar; 92(6-7):383-92. PubMed ID: 23353874
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative study of liposomes, transfersomes and ethosomes as carriers for improving topical delivery of celecoxib.
    Bragagni M; Mennini N; Maestrelli F; Cirri M; Mura P
    Drug Deliv; 2012; 19(7):354-61. PubMed ID: 23043648
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Preparation and evaluation of solid lipid nanoparticles based nanogel for dermal delivery of meloxicam.
    Khurana S; Bedi PM; Jain NK
    Chem Phys Lipids; 2013; 175-176():65-72. PubMed ID: 23994283
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In situ intestinal permeability and in vivo oral bioavailability of celecoxib in supersaturating self-emulsifying drug delivery system.
    Song WH; Yeom DW; Lee DH; Lee KM; Yoo HJ; Chae BR; Song SH; Choi YW
    Arch Pharm Res; 2014 May; 37(5):626-35. PubMed ID: 23852645
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Formulation and Characterization of Aceclofenac -Aloe vera Transemulgel.
    Raju YP; Haritha K; Satyanarayana RP; Vandana KR; Bindu DT; Vinesha V; Chowdary VH
    Curr Drug Deliv; 2015; 12(6):703-8. PubMed ID: 25751659
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nano-proniosomes enhancing the transdermal delivery of mefenamic acid.
    Wen MM; Farid RM; Kassem AA
    J Liposome Res; 2014 Dec; 24(4):280-9. PubMed ID: 24779560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.